GPC Biotech AG
Records under this name other than patents GPC Biotech AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,232,283 | Raf Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,450,348 | Derivatives of Squaric Acid with Anti-Proliferative Activity Formerly held In force · High confidence | In force | High confidence | |
| US 8,518,958 | Pyrido [2,3-d] Pyrimidines and Their Use as Kinase Inhibitors Formerly held Lapsed on the fee record Ended Aug 27, 2025 · High confidence | Lapsed on the fee record | Ended Aug 27, 2025 | High confidence |
| US 8,084,457 | Pharmaceutically Active 4,6-Disubstituted Aminopyrimidine Derivatives as Modulators of Protein Kinases Formerly held Term ended Term ended Sep 15, 2024 · High confidence | Term ended | Term ended Sep 15, 2024 | High confidence |
| US 8,304,418 | Pyrazolopyrimidinone kinase inhibitor Formerly held Lapsed on the fee record Ended Nov 6, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2016 | From the USPTO record |
| US 6,753,329 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto Lapsed on the fee record Ended Jun 22, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2016 | From the USPTO record |
| US 8,048,888 | Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and EGFR inhibitors or pyrimidine analogues Lapsed on the fee record Ended Nov 1, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 1, 2015 | From the USPTO record |
| US 7,230,101 | Synthesis of methotrexate-containing heterodimeric molecules Formerly held Lapsed on the fee record Ended Jun 12, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2015 | From the USPTO record |
| US 7,135,550 | Three hybrid assay system Formerly held Lapsed on the fee record Ended Nov 14, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2014 | From the USPTO record |
| US 6,423,519 | Compositions and methods for inhibiting fungal growth Lapsed on the fee record Ended Jul 23, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 23, 2014 | From the USPTO record |